Ryan & Maniskas, LLP Announces Investigation Of Somanetics Corporation

Ryan & Maniskas, LLP ( www.rmclasslaw.com/cases/smts) is investigating potential claims against the board of directors of Somanetics Corporation ("Somanetics" or the "Company") (NASDAQ: SMTS) concerning possible breaches of fiduciary duty and other violations of law related to the Company's entry into an agreement to be acquired by Covidien plc.

Our investigation concerns possible breaches of fiduciary duty and other violations of law related to approval of the transaction by Company’s board of directors; in particular, whether the Company undertook a fair process to obtain fair consideration for all shareholders of Somanetics. For more information regarding our investigation, please contact Ryan & Maniskas, LLP (Richard A. Maniskas, Esquire) toll-free at [phone] or by email at [e-mail] or visit: www.rmclasslaw.com/cases/smts.

Under the proposed agreement, Somanetics shareholders will receive $25.00 in cash for each Somanetics share of common stock they own.

If you own shares of Somanetics and would like to learn more about these claims or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at [phone] or to sign up online, visit: www.rmclasslaw.com/cases/smts. You may also email Mr. Maniskas at [e-mail]. For more information about class action cases in general, please visit our website: www.rmclasslaw.com.

Ryan & Maniskas, LLP is a national shareholder litigation firm. Ryan and Maniskas, LLP is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide.

>To order reprints of this article, click here: Reprints